RVL Pharmaceuticals plc Long-Term Debt, Maturity, Year Five
RVL Pharmaceuticals plc had Long-Term Debt, Maturity, Year Five of $33.00 million as of 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2022-03-30
- 2021-12-31: Long-Term Debt, Maturity, Year Five $33.00M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2021-12-31 | $33.00M 10-K · filed 2022-03-30 |